177Lu-PSMA-617 Managed Access Program for mCRPC Patients

NCT04825652 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Interventions

DRUG: 177Lu-PSMA-617
DRUG: PSMA-11

Sponsor

Advanced Accelerator Applications